Tower Research Capital (TRC)’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.5K | Buy |
1,320
+1,091
| +476% | +$71.6K | ﹤0.01% | 2450 |
|
|
2025
Q4 | $14.1K | Sell |
229
-586
| -72% | -$37.8K | ﹤0.01% | 3369 |
|
|
2025
Q3 | $59.6K | Buy |
815
+23
| +3% | +$1.81K | ﹤0.01% | 2384 |
|
|
2025
Q2 | $58.9K | Buy |
792
+422
| +114% | +$29.5K | ﹤0.01% | 2832 |
|
|
2025
Q1 | $27.7K | Sell |
370
-1,099
| -75% | -$102K | ﹤0.01% | 2679 |
|
|
2024
Q4 | $150K | Buy |
1,469
+1,144
| +352% | +$131K | ﹤0.01% | 1899 |
|
|
2024
Q3 | $34.3K | Sell |
325
-547
| -63% | -$55.9K | ﹤0.01% | 2934 |
|
|
2024
Q2 | $81.2K | Buy |
872
+719
| +470% | +$76.3K | ﹤0.01% | 2735 |
|
|
2024
Q1 | $19.9K | Sell |
153
-1,525
| -91% | -$179K | ﹤0.01% | 3006 |
|
|
2023
Q4 | $190K | Sell |
1,678
-479
| -22% | -$41.5K | ﹤0.01% | 2141 |
|
|
2023
Q3 | $177K | Buy |
2,157
+1,960
| +995% | +$172K | 0.01% | 1519 |
|
|
2023
Q2 | $18.5K | Sell |
197
-147
| -43% | -$11.7K | ﹤0.01% | 3455 |
|
|
2023
Q1 | $24K | Buy |
344
+213
| +163% | +$17.2K | ﹤0.01% | 3228 |
|
|
2022
Q4 | $9K | Sell |
131
-403
| -75% | -$27.5K | ﹤0.01% | 4165 |
|
|
2022
Q3 | $33K | Sell |
534
-459
| -46% | -$33.1K | ﹤0.01% | 3517 |
|
|
2022
Q2 | $66K | Sell |
993
-771
| -44% | -$57.9K | ﹤0.01% | 2632 |
|
|
2022
Q1 | $127K | Buy |
1,764
+321
| +22% | +$26.3K | ﹤0.01% | 2034 |
|
|
2021
Q4 | $138K | Sell |
1,443
-442
| -23% | -$29.9K | ﹤0.01% | 2022 |
|
|
2021
Q3 | $93K | Buy |
1,885
+1,550
| +463% | +$77.9K | ﹤0.01% | 2462 |
|
|
2021
Q2 | $17K | Buy |
+335
| New | +$16.5K | ﹤0.01% | 4030 |
|
|
2021
Q1 | – | Sell |
-628
| Closed | -$18K | – | 5413 |
|
|
2020
Q4 | $18K | Buy |
+628
| New | +$16.1K | ﹤0.01% | 3926 |
|
|
2020
Q3 | – | Sell |
-2,102
| Closed | -$18K | – | 4828 |
|
|
2020
Q2 | $18K | Buy |
2,102
+531
| +34% | +$3.28K | ﹤0.01% | 3727 |
|
|
2020
Q1 | $8K | Buy |
+1,571
| New | +$17.7K | ﹤0.01% | 2107 |
|
|
2019
Q3 | – | Sell |
-1,891
| Closed | -$37K | – | 4103 |
|
|
2019
Q2 | $37K | Buy |
1,891
+1,674
| +771% | +$38.2K | ﹤0.01% | 1782 |
|
|
2019
Q1 | $6K | Sell |
217
-11,615
| -98% | -$330K | ﹤0.01% | 2931 |
|
|
2018
Q4 | $292K | Buy |
11,832
+11,322
| +2,220% | +$278K | 0.02% | 581 |
|
|
2018
Q3 | $16K | Buy |
+510
| New | +$18.4K | ﹤0.01% | 2474 |
|
|
2018
Q2 | – | Sell |
-1,776
| Closed | -$58K | – | 3661 |
|
|
2018
Q1 | $58K | Sell |
1,776
-14,824
| -89% | -$275K | 0.01% | 1598 |
|
|
2017
Q4 | $162K | Buy |
16,600
+15,616
| +1,587% | +$146K | 0.02% | 647 |
|
|
2017
Q3 | $10K | Buy |
984
+884
| +884% | +$9.17K | ﹤0.01% | 3061 |
|
|
2017
Q2 | $1K | Buy |
+100
| New | +$994 | ﹤0.01% | 2460 |
|
|
2016
Q4 | – | Sell |
-130
| Closed | -$1K | – | 3838 |
|
|
2016
Q3 | $1K | Buy |
130
+125
| +2,500% | +$1.03K | ﹤0.01% | 3261 |
|
|
2016
Q2 | $0 | Buy |
+5
| New | +$35 | ﹤0.01% | 4444 |
|
|
2016
Q1 | – | Sell |
-38
| Closed | – | – | 4145 |
|
|
2015
Q4 | $0 | Buy |
+38
| New | +$250 | ﹤0.01% | 4497 |
|
|
2015
Q3 | – | Sell |
-8
| Closed | – | – | 4032 |
|
|
2015
Q2 | $0 | Buy |
+8
| New | +$88 | ﹤0.01% | 4409 |
|
|
2015
Q1 | – | Sell |
-45
| Closed | -$1K | – | 4414 |
|
|
2014
Q4 | $1K | Sell |
45
-353
| -89% | -$4.19K | ﹤0.01% | 3596 |
|
|
2014
Q3 | $5K | Sell |
398
-307
| -44% | -$3.88K | ﹤0.01% | 3265 |
|
|
2014
Q2 | $10K | Sell |
705
-1,561
| -69% | -$20.2K | ﹤0.01% | 2342 |
|
|
2014
Q1 | $29K | Buy |
+2,266
| New | +$35.4K | ﹤0.01% | 1525 |
|
Other funds holding BXC
GJL
JCP
VCM
PAIM
RRAM
Tower Research Capital (TRC)'s BXC Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its BlueLinx (BXC) stake by 476% in Q1 2026, buying an estimated $71.6K and bringing the position to 1,320 shares worth $71.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2450.
Tower Research Capital (TRC) first reported a position in BXC in Q1 2014 and has held it in 39 quarters since. The position peaked at $292K in Q4 2018. 145 funds tracked by Wall St. Rank hold BXC as of Q1 2026.
- Tower Research Capital (TRC) held 1,320 shares of BlueLinx worth $71.5K as of Q1 2026.
- Tower Research Capital (TRC) bought 1,091 BlueLinx shares in Q1 2026, an estimated $71.6K.
- BlueLinx made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2450 holding.
- Tower Research Capital (TRC) first reported a position in BlueLinx in Q1 2014 and has held it in 39 quarters since.
- Tower Research Capital (TRC)'s BlueLinx position peaked at $292K in Q4 2018.
- 145 funds tracked by Wall St. Rank held BlueLinx as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.